参考文献/References:
[1] Singhal A, Tripathi M. Refractory status epilepticus [J].
Neurology Asia, 2013, 18: 67-71.
[2] Goodkin HP, Yeh JL, Kapur J. Status epilepticus increases
the intracellular accumulation of GABAA receptors [J]. J
Neurosci, 2005, 25(23): 5511-5520.
[3] Naylor DE, Liu H, Niquet J, et al. Rapid surface accumula-
tion of NMDA receptors increases glutamatergic excitation
during status epilepticus [J]. Neurobiol Dis, 2013, 8(13):
54: 225-238.
[4] Vezzani A, Rüegg S. Immunity and inflammation in epilepsy:
mechanistic insights and therapeutic perspectives [J]. Epi-
lepsia, 2011, 52(Suppl 3): 1-53.
[5] Treiman DM, Meyers PD, Walton NY, et al. A comparison of
four treatments for generalized convulsive status epilepticus
[J]. N Engl J Med, 1998, 339(12): 792-798.
[6] Power KN, Flaatten H, Gilhus NE, et al. Propofol treatment
in adult refractory status epilepticus: mortality risk and out-
come [J]. Epilepsy Res, 2011, 94(1): 53-60.
[7] Claassen J, Hirsch LJ, Emerson RG, et al. Treatment of re-
fractory status epilepticus with pentobarbital, propofol, or
midazolam: a systematic review [J]. Epilepsia, 2002, 43(2):
146-153.
[8] Rossetti AO, Milligan TA, Vulliémoz S, et al. A randomized
trial for the treatment of refractory status epilepticus [J].
Neurocrit Care, 2011, 14(1): 4-10.
[9] Hsieh CY, Sung PS, Tsai JJ, et al. Terminating prolonged
refractory status epilepticus using ketamine [J]. Clin Neu-
ropharmacol, 2010, 33(3): 165-167.
[10] Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketoge-
nic diet in severe refractory status epilepticus initiating
fever induced refractory epileptic encephalopathy in school
age children (FIRES) [J]. Epilepsia, 2010, 51(10): 2033-
2037.
[11] Granata T, Fusco L, Gobbi G, et al. Experience with immu-
nomodulatory treatments in Rasmussen's encephalitis [J].
Neurology, 2003, 61(12): 1807-1810.
[12] Lhatoo SD, Alexopoulos AV. The surgical treatment of status
epilepticus [J]. Epilepsia, 2007, 48(s8): 61-65.
[13] 吴学群，彭付学，王 威，等. 颅脑损伤后癫痫持续状态
的救治体会[J]. 中国临床神经外科杂志，2008，13（7）：
423-424.
[14] Ma X, Liporace J, O'Connor MJ, et al. Neurosurgical treat-
ment of medically intractable status epilepticus [J]. Epilepsy
Res, 2001, 46(1): 33-38.
[15] 刘强强，徐纪文，田 鑫，等. 迷走神经刺激治疗难治性癫
痫持续状态一例并文献复习[J]. 中华神经外科杂志，
2011，27（11）：1111-1112.
[16] Franzini A, Messina G, Marras C, et al. Deep brain stimula-
tion of two unconventional targets in refractory non-resec-
table epilepsy [J]. Stereotact Funct Neurosurg, 2008, 86(6):
373-381.
[17] Rotenberg A, Bae EH, Takeoka M, et al. Repetitive trans-
cranial magnetic stimulation in the treatment of epilepsia
partialis continua [J]. Epilepsy Behav, 2009, 14(1): 253-
257.
[18] Lambrecq V, Villéga F, Marchal C, et al. Refractory status
epilepticus: electroconvulsive therapy as a possible thera-
peutic strategy [J]. Seizure, 2012, 21(9): 661-664.
相似文献/References:
[1]唐 铸 桂 铮 李延良 赵建伍 余天垒 张鹏飞 赵立文 于耀宇.药物PAS与支架置入术治疗症状性颈动脉重度狭窄的近期疗效对比分析[J].中国临床神经外科杂志,2015,(12):727.[doi:10.13798/j.issn.1009-153X.2015.12.007]
TANG Zhu,GUI Zheng,LI Yan-liang,et al.Comparison of clinical effect of intensive therapy with PAS on severe symptomatic carotid artery stenosis with that of carotid artery stenting[J].,2015,(02):727.[doi:10.13798/j.issn.1009-153X.2015.12.007]
[2]旷仁钊 综述 唐晓平 审校.蛛网膜下腔出血后脑血管痉挛药物治疗的研究进展[J].中国临床神经外科杂志,2015,(09):572.[doi:10.13798/j.issn.1009-153X.2015.09.024]
[3]刘骏辉 综述 陈谦学 审校.动脉瘤性蛛网膜下腔出血后抗血管痉挛的药物治疗[J].中国临床神经外科杂志,2016,(08):504.[doi:10.13798/j.issn.1009-153X.2016.08.024]
[4]廖建明 综述 陈谦学 审校.自发性脑出血急性期药物治疗研究进展[J].中国临床神经外科杂志,2017,(12):857.[doi:10.13798/j.issn.1009-153X.2017.12.021]
[5]曾子桓 张 灏 魏梁锋 王守森.颅脑损伤动物研究中天然化合物的应用现状[J].中国临床神经外科杂志,2019,(11):710.[doi:10.13798/j.issn.1009-153X.2019.11.026]
[6]常盼盼 吕传祥 孙广超 李毅平 徐梦奇 唐东方 陈锋.诺卡菌导致颅内多发脑脓肿1例[J].中国临床神经外科杂志,2020,(06):416.[doi:10.13798/j.issn.1009-153X.2020.06.028]
[7]刘 晗 连海伟 刘仁忠.鞍旁脑膜瘤的诊治研究进展[J].中国临床神经外科杂志,2021,26(05):374.[doi:10.13798/j.issn.1009-153X.2021.05.020]
[8]孙亚雪,谢春美,赵庚水,等.脑膜瘤药物治疗的研究进展[J].中国临床神经外科杂志,2024,29(03):181.[doi:10.13798/j.issn.1009-153X.2024.03.013]
SUN Ya-xue,XIE Chun-mei,ZHAO Geng-shui,et al.Research progress in drug therapy for meningiomas[J].,2024,29(02):181.[doi:10.13798/j.issn.1009-153X.2024.03.013]
[9]张诚,王继超.难治性垂体腺瘤的药物治疗进展[J].中国临床神经外科杂志,2024,29(10):616.[doi:10.13798/j.issn.1009-153X.2024.10.010]
ZHANG Cheng,WANG Ji-chao.Progress of drug therapy for refractory pituitary adenomas[J].,2024,29(02):616.[doi:10.13798/j.issn.1009-153X.2024.10.010]